Immunovant
在场
是其中之一......
Sumitomo Chemical 是一家在股票代码 4005 (JP) 下上市的公司。
Sumitomo Chemical 在 6 个国家有直接业务。Sumitomo Chemical 拥有 27家子公司，其中包括 Asahi Chemical、Covant Therapeutics 和 Datavant。
他们在：
高管
查看带有其 41 名主要高管的组织结构图
Immunovant 搜索最多的简介
- Pete Salzmann, Chief Executive Officer and Director
- George Migausky, Director
- Douglas Hughes, Director
高管在Immunovant变化
- Melanie Gloria已作为Chief Operating Officer加入公司 (新闻发布的2024十一月26号).
创建提醒
跟踪 Immunovant 的高管变动
生物技术
Sumitomo Chemical 拥有 2,328 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Integral Diagnostics and Capitol Health Limited have announced they will merge (公布2024十一月26号)..
- Inbrain Neuroelectronics 刚刚宣布为 50 筹款数百万美元。 (公布2024十一月23号).
- Chromocell的新名称是Channel Therapeutics Corporation。 (公布2024十一月22号).
生物技术 行业的其他推荐联系人
消息
Immunovant 的最新新闻稿
- Immunovant Provides Development Updates and Reports Financial Results for the Quarter Ended September 30, 2024
- Immunovant Announces Oral Presentation of Late Breaking Abstract for Phase 2 Graves’ Disease Clinical Data at the 2024 American Thyroid Association (ATA) Annual Meeting
- Immunovant Provides Update on Graves’ Disease Development Program
- Immunovant to Host Graves’ Disease Program Update on September 9, 2024
- Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended June 30, 2024
- Press Releases
- Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024
- Immunovant Awarded U.S. Patent for IMVT-1402
- Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended December 31, 2023
- Immunovant to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- View more press releases Close
关于 Immunovant 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Pete Salzmann 
